BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35439717)

  • 1. Regional changes of brain structure during progression of idiopathic Parkinson's disease - A longitudinal study using deformation based morphometry.
    Pieperhoff P; Südmeyer M; Dinkelbach L; Hartmann CJ; Ferrea S; Moldovan AS; Minnerop M; Diaz-Pier S; Schnitzler A; Amunts K
    Cortex; 2022 Jun; 151():188-210. PubMed ID: 35439717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
    J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
    Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
    Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal ganglia atrophy-associated causal structural network degeneration in Parkinson's disease.
    Li R; Zou T; Wang X; Wang H; Hu X; Xie F; Meng L; Chen H
    Hum Brain Mapp; 2022 Feb; 43(3):1145-1156. PubMed ID: 34792836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
    Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
    BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry.
    Nürnberger L; Gracien RM; Hok P; Hof SM; Rüb U; Steinmetz H; Hilker R; Klein JC; Deichmann R; Baudrexel S
    Neuroimage Clin; 2017; 13():405-414. PubMed ID: 28116233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
    Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
    Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of emotions conveyed by voice in Parkinson's disease: Association between variability of fundamental frequency and gray matter volumes of regions involved in emotional prosody.
    Anzuino I; Baglio F; Pelizzari L; Cabinio M; Biassoni F; Gnerre M; Blasi V; Silveri MC; Di Tella S
    Neuropsychology; 2023 Nov; 37(8):883-894. PubMed ID: 37439736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging.
    Zeighami Y; Fereshtehnejad SM; Dadar M; Collins DL; Postuma RB; Mišić B; Dagher A
    Neuroimage; 2019 Apr; 190():69-78. PubMed ID: 29277406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal deformation-based morphometry reveals spatio-temporal dynamics of brain volume changes in patients with corticobasal syndrome.
    Südmeyer M; Pieperhoff P; Ferrea S; Krause H; Groiss SJ; Elben S; Wojtecki L; Zilles K; Amunts K; Schnitzler A
    PLoS One; 2012; 7(7):e41873. PubMed ID: 22848644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using (18) F-FP-CIT.
    Choi H; Cheon GJ; Kim HJ; Choi SH; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
    Hum Brain Mapp; 2016 May; 37(5):1710-21. PubMed ID: 26846350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Brain Volume in REM Sleep Behavior Disorder with Mild Cognitive Impairment.
    Rémillard-Pelchat D; Rahayel S; Gaubert M; Postuma RB; Montplaisir J; Pelletier A; Monchi O; Brambati SM; Carrier J; Gagnon JF
    J Parkinsons Dis; 2022; 12(1):229-241. PubMed ID: 34690149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gray Matter Volume Loss in Proposed Brain-First and Body-First Parkinson's Disease Subtypes.
    Banwinkler M; Dzialas V; ; Hoenig MC; van Eimeren T
    Mov Disord; 2022 Oct; 37(10):2066-2074. PubMed ID: 35943058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced lateral occipital gray matter volume is associated with physical frailty and cognitive impairment in Parkinson's disease.
    Chen YS; Chen HL; Lu CH; Chen MH; Chou KH; Tsai NW; Yu CC; Chiang PL; Lin WC
    Eur Radiol; 2019 May; 29(5):2659-2668. PubMed ID: 30523452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
    Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT
    Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voxel-based morphometry of grey matter structures in Parkinson's Disease with wearing-off.
    Zhai H; Fan W; Xiao Y; Zhu Z; Ding Y; He C; Zhang W; Xu Y; Zhang Y
    Brain Imaging Behav; 2023 Dec; 17(6):725-737. PubMed ID: 37735325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of diffusion kurtosis changes in Parkinson's disease subtypes.
    Sejnoha Minsterova A; Klobusiakova P; Pies A; Galaz Z; Mekyska J; Novakova L; Nemcova Elfmarkova N; Rektorova I
    Parkinsonism Relat Disord; 2020 Dec; 81():96-102. PubMed ID: 33120076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.